摘要
促红细胞生成素(Epo)是一种糖蛋白激素,在促红细胞生成和神经保护中具有重要作用,目前认为Epo在新生儿高氧肺损伤、早产儿视网膜病及新生儿坏死性小肠结肠炎中也有一定的保护效应。重组人促红细胞生成素(rhEpo)作为其基因克隆物已广泛应用于新生儿领域。
Erythropoientin(Epo),a glycoprotein hormone,plays an important role in erythropoiesis and neuroprotection.Recently,Epo is also considered to have protective effects against hyperoxic lung injury,retinopathy of prematurity and neonatal necrotizing enterocolitis.Recombinant human erythropietin(rhEpo) as Epo gene cloning drug has been widely used in neonatal clinical practice.
出处
《中国当代儿科杂志》
CAS
CSCD
北大核心
2011年第12期1007-1010,F0003,共5页
Chinese Journal of Contemporary Pediatrics